7-(chloromethyl)-2-cyclopropyl-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one, 95.0%, 5g

3-Fluoro-4-methoxybenzimidamide, 98%, 500mg

2-Amino-4,5-dimethyl-1-phenyl-1H-pyrrole-3-carbonitrile, 95.0%, 5g

[1,1'-Biphenyl]-4,4'-dicarbaldehyde, 95.0%, 5g

Fmoc-D-2-Fluoro-4-chlorophenylalanine, 97%, 100mg

2,2,2-Trifluoro-1,1-dimethyl-ethylamine, 98.0%, 250mg

BENZYL 2,3-DIBROMOPROPANOATE, 95.0%, 5g

Sodium 4-amino-2-hydroxybenzoate dihydrate, 98.0%, 25g

(3-METHYLPYRROLIDIN-3-YL)METHANAMINE 2HCL, 95.0%, 500mg

N,N-Diisopropylethylamine (DIPEA), 100mL, >=99.5%, pour la synthèse peptidique, emballage en verre

Sodium; 5-ethoxycarbonyl-4-methyl-pyrimidin-2-olate, 95.0%, 1g

3-Amino-5-bromoindazole, 97%, 25g

N-Cbz-1,2,5,6-tetrahydropyridine, 95.0%, 25g